TABLE 1.
Parent, Child, and Care Characteristics (N = 95)
| Parent Characteristics | Percentagea |
|---|---|
| Sex | |
| Female | 81 |
| Male | 19 |
| Education | |
| >High school | 82 |
| ≤High school | 18 |
| Race/ethnicity | |
| White | 58 |
| Black | 8 |
| Hispanic | 23 |
| Other | 11 |
| Site | |
| Boston Children’s Hospital/Dana-Farber Cancer Institute | 22 |
| Children’s Hospital Los Angeles | 18 |
| Children’s Hospital of Philadelphia | 20 |
| Columbia University Irving Medical Center | 3 |
| Cook Children’s Medical Center | 7 |
| Seattle Children’s Research Institute | 6 |
| St. Jude Children’s Research Hospital | 6 |
| Lucile Packard Children’s Hospital at Stanford | 9 |
| University of Chicago | 7 |
| Care at study site | |
| Primary oncology care | 64 |
| Second opinion | 36 |
| Child Characteristics | |
| Sex | |
| Female | 40 |
| Male | 60 |
| Median age at parent enrollment (IQR), y | 6 (4–8) |
| Care and Treatment Characteristics | |
| Neuroblastoma status | |
| Recurrent | 76 |
| Refractory to initial therapy | 23 |
| Median mo between diagnosis and first recurrence (IQR) | 13 (5–24) |
| Median mo between first recurrence and survey (IQR) | 11 (5–25) |
| Median no. of prior chemotherapeutic regimens (IQR) | 3 (2–5) |
| Median no. of prior clinical trials (IQR) | 1 (1–2) |
| Documented treatment options | 80 |
| Experimental therapy on a phase 1/2 clinical trial | 58 |
| Established high-intensity regimen | 41 |
| Established low-intensity regimen | 26 |
| No cancer-directed therapy | 12 |
| Treatment decision | |
| Experimental therapy on a phase 1/2 clinical trial | 43 |
| Established high-intensity regimen | 27 |
| Established low-intensity regimen | 26 |
| No cancer-directed therapy | 5 |
| Documented prognosis discussion since last recurrence | 33 |
| Medical care since last recurrence | |
| >5 hospital d/mo | 26 |
| >5 outpatient or emergency department visits/mo | 8 |
| ICU care | 13 |
| Mechanical ventilation | 1 |
| Blood pressure support | 1 |
| Bacteremia | 9 |
| Highly myelosuppressive therapy requiring stem cell infusion | 18 |
| Composite outcomes | |
| Any of the above | 49 |
| Frequent inpatient or outpatient visitsb | 29 |
| Intensive medical carec | 19 |
| Care and Treatment Characteristics | |
| Palliative care discussion | 7 |
| Hospice use | 2 |
| DNR order or home comfort care form | 0 |
Abbreviations: DNR, do not resuscitate; ICU, intensive care unit, IQR, inter-quartile range.
Shown as the percentage unless otherwise specified.
More than 5 hospital days or >5 outpatient/emergency department visits per 30 days.
Any ICU care, mechanical ventilation, blood pressure support, or bacteremia.